NASDAQ: TRDA
Entrada Therapeutics Inc Stock Ownership - Who owns Entrada Therapeutics?

Insider buying vs selling

Have Entrada Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mpm Bioventures 2014 LP10% Owner2024-12-1121,787$20.23
$440.75kSell
Mpm Bioventures 2018 LP10% Owner2024-12-1121,787$20.23
$440.75kSell
Mpm Bioventures 2014 LP10% Owner2024-12-1022,935$20.77
$476.36kSell
Mpm Bioventures 2018 LP10% Owner2024-12-1022,935$20.77
$476.36kSell
Natarajan SethuramanPresident Research Develop.2024-12-0311,703$20.15
$235.79kSell
Kory James WentworthChief Financial Officer2024-12-025,000$20.00
$99.98kSell
Natarajan SethuramanPresident Research Develop.2024-12-024,088$20.26
$82.84kSell
Kory James WentworthChief Financial Officer2024-12-025,000$2.10
$10.50kBuy
Kory James WentworthChief Financial Officer2024-11-291,000$19.97
$19.97kSell
Kory James WentworthChief Financial Officer2024-11-291,000$2.10
$2.10kBuy

1 of 9

TRDA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRDA insiders and whales buy or sell their stock.

TRDA Shareholders

What type of owners hold Entrada Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP13.00%4,865,819$65.98MInstitution
Baker Bros Advisors LP12.03%4,501,658$61.04MInsider
Mpm Asset Management LLC11.83%4,425,784$60.01MInstitution
Todd Foley11.83%4,425,784$60.01MInsider
5am Venture Management LLC11.78%4,408,379$59.78MInstitution
Mpm Bioventures 2018 LP11.71%4,381,062$59.41MInsider
Mpm Bioventures 2014 LP11.71%4,381,062$59.41MInsider
Price T Rowe Associates Inc8.15%3,049,572$41.35MInstitution
Roche Holding Ltd7.52%2,813,525$38.15MInsider
Redmile Group LLC5.22%1,954,420$26.50MInsider

1 of 3

TRDA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRDA54.07%45.93%Net SellingNet Selling
ERAS72.96%27.04%Net BuyingNet Buying
EYPT22.81%77.19%Net BuyingNet Selling
OMER43.19%6.75%
MGTX47.67%52.33%Net BuyingNet Selling

Entrada Therapeutics Stock Ownership FAQ

Who owns Entrada Therapeutics?

Entrada Therapeutics (NASDAQ: TRDA) is owned by 80.44% institutional shareholders, 68.34% Entrada Therapeutics insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Entrada Therapeutics shareholder, owning 4.50M shares representing 12.03% of the company. Baker Bros Advisors LP's Entrada Therapeutics shares are currently valued at $62.98M.

If you're new to stock investing, here's how to buy Entrada Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.